Calliditas Therapeutics had a typical to-do list for its midphase head and neck cancer study. Step one, show the molecule ...

Q2 2024 Earnings Call Transcript May 6, 2024 Enanta Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge ...

Key Takeaways An experimental anti-nicotine drug helps people quit vaping Vapers taking cytisinicline were twice as likely to quit as people taking a placebo The drug binds to nicotine receptors in ...

Early research suggests setanaxib combined with pembrolizumab may be a promising treatment for patients with squamous cell carcinoma of the head and neck.

Phase 2 ORCA-V1 trial showed treatment with cytisinicline more than doubled odds of quitting e-cigarettes compared with placebo Cytisinicline treatment well tolerated with no serious adverse events ...

(RTTNews) - NeuroSense Therapeutics (NRSN) announced new analyses from Phase 2b PARADIGM clinical trial, demonstrated a statistically significant slowing of disease progression in high-risk ALS ...

An experimental anti-nicotine drug appears to help people quit vaping, a new study says. Cytisinicline is a naturally occurring plant-based substance that binds to nicotine receptors in the brain, ...

Science-backed evidence may be lacking about the efficacy of homeopathy, but it is the second most popular medicinal ...

A single dose of an LSD-containing investigational drug rapidly alleviated symptoms of moderate-to-severe generalized anxiety ...

A supplement formulated with American ginseng, Brahmi, and coffee fruit extract could improve mood and working memory, ...

Madrigal also expects to reinforce Rezdiffra’s clinical profile—and potentially convert the current accelerated approval to a full nod—with patient outcomes data from the MAESTRO-NASH trial. That ...

Data on several novel injectable drugs were presented at the World Congress on Osteoarthritis, as well as updated data on the gene therapy XT-150.